Cargando…
Models of Excellence: Improving Oncology Drug Development
Autores principales: | Sharma, Manish R., Maitland, Michael L., Ratain, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837384/ https://www.ncbi.nlm.nih.gov/pubmed/23085878 http://dx.doi.org/10.1038/clpt.2012.99 |
Ejemplares similares
-
Estimation of renal cell carcinoma treatment effects from disease progression modeling
por: Maitland, Michael L., et al.
Publicado: (2012) -
A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence
por: Sharma, Pramod Kumar, et al.
Publicado: (2018) -
Editorial: Global excellence in oncology: Asia and Australia 2021
por: Zhang, Kun
Publicado: (2022) -
Editorial: Global excellence in oncology: Latin America 2022
por: Camacho, Javier, et al.
Publicado: (2022) -
Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
por: Ratain, Mark J., et al.
Publicado: (2022)